We are live on ! Find out more
HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of HTGM yet.

HTGM Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q2 2023, worth a combined $0 — down 100% from $67.3K a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of HTGM and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $39.7K sold.

  • 0 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q2 2023, down from 12 in Q1 2023.
  • Funds reported $0 of HTG Molecular Diagnostics, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q2 2023 and 12 closed out, a net change of -12 holders.
  • The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q2 2023 was Vanguard Group, an estimated $39.7K sold.

Based on aggregated 13F filings for Q2 2023.